期刊
MOLECULAR PHARMACEUTICS
卷 -, 期 -, 页码 -出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.0c00694
关键词
nanomedicine; alimentary canal; systemic drug delivery; local drug delivery; enteral administration
资金
- American Foundation for Pharmaceutical Education through the Dr. Paul B. Myrdal Memorial Fund
- Oregon State University College of Pharmacy
The field of nanomedicine is expanding with new technologies and formulations being developed for various disease states. Research is focusing on injectable nanomedicines for treating neoplasms, but there are also developments in using nanotechnology for enteral administration in noncancer indications. Studies highlight the potential of nanodrug delivery along the alimentary canal for systemic or local drug delivery.
The field of nanomedicine continues to grow with new technologies and formulations in development for several disease states. Much research focuses on the use of injectable nanomedicines for treatment of neoplasms; however, there are several formulations in development that use nanotechnology that can be administered enterally for noncancer indications. These nanomedicine treatments have been developed for systemic drug delivery or local drug delivery along the gastrointestinal tract. This Review gives a brief overview of the alimentary canal and highlights new research in nanomedicine in noncancer disease states delivered via enteral routes of administration. Relevant recent research is summarized on the basis of the targeted site of action or absorption, including the buccal, sublingual, stomach, small intestine, and large intestine areas of the alimentary canal. The benefits of nanodrug delivery are discussed as well as barriers and challenges for future development in the field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据